Form 8-K for ARIAD PHARMACEUTICALS INC
ITEM 8.01 Other Events.
Frank G. Haluska, M.D., Ph.D., the Senior Vice President, Clinical Research and Development and Chief Medical Officer of ARIAD Pharmaceuticals, Inc. (the “Company”), has resigned from the Company, effective as of May 6, 2016, to take a position as chief executive officer of an oncology company. Sergio Santillana, M.D., the Company’s Vice President, Clinical R&D, has been appointed as Acting Chief Medical Officer, effective upon Dr. Haluska’s departure, and reporting to Timothy P. Clackson, Ph.D., President of Research and Development and Chief Scientific Officer.
Thomas J. DesRosier, Esq., the Company’s Executive Vice President, Chief Legal and Administrative Officer and Secretary, has resigned from the Company, effective as of April 30, 2016, to pursue other opportunities. Scott A. Samuels, Esq., the Company’s Assistant General Counsel, has been appointed as Acting General Counsel and Secretary, effective upon Mr. DesRosier’s departure.